The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
8-methoxy-5-(4-methoxybenzyl)-1-methyl-4-oxo-3,4-dihydro-5H-pyridazino[4,5-b]indole ID: ALA2088676
PubChem CID: 70687030
Max Phase: Preclinical
Molecular Formula: C20H19N3O3
Molecular Weight: 349.39
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: COc1ccc(Cn2c3ccc(OC)cc3c3c(C)n[nH]c(=O)c32)cc1
Standard InChI: InChI=1S/C20H19N3O3/c1-12-18-16-10-15(26-3)8-9-17(16)23(19(18)20(24)22-21-12)11-13-4-6-14(25-2)7-5-13/h4-10H,11H2,1-3H3,(H,22,24)
Standard InChI Key: JMZDXQIZYZGFQD-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 29 0 0 0 0 0 0 0 0999 V2000
4.3022 1.0124 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3011 0.1852 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0158 -0.2277 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0140 1.4251 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7293 1.0161 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7295 0.1851 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5199 -0.0706 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.5195 1.2730 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0050 0.5997 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8289 0.6843 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1683 1.4416 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.6776 2.1151 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.8554 2.0271 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3122 0.0158 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.3700 2.6941 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9295 -0.7867 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5142 -1.4994 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6912 -1.4929 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2760 -2.2047 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6857 -2.9217 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5148 -2.9224 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9263 -2.2099 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5877 1.4247 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.8734 1.0121 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2713 -3.6350 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.4464 -3.6328 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 3 1 0
12 13 2 0
13 8 1 0
3 6 2 0
10 14 2 0
6 7 1 0
13 15 1 0
7 9 1 0
7 16 1 0
8 5 1 0
16 17 1 0
1 2 2 0
17 18 2 0
5 4 2 0
18 19 1 0
8 9 2 0
19 20 2 0
4 1 1 0
20 21 1 0
9 10 1 0
21 22 2 0
22 17 1 0
5 6 1 0
1 23 1 0
10 11 1 0
23 24 1 0
20 25 1 0
11 12 1 0
25 26 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 349.39Molecular Weight (Monoisotopic): 349.1426AlogP: 3.25#Rotatable Bonds: 4Polar Surface Area: 69.14Molecular Species: NEUTRALHBA: 5HBD: 1#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 10.73CX Basic pKa: ┄CX LogP: 2.49CX LogD: 2.49Aromatic Rings: 4Heavy Atoms: 26QED Weighted: 0.61Np Likeness Score: -0.96
References 1. Bruel A, Logé C, Tauzia ML, Ravache M, Le Guevel R, Guillouzo C, Lohier JF, Oliveira Santos JS, Lozach O, Meijer L, Ruchaud S, Bénédetti H, Robert JM.. (2012) Synthesis and biological evaluation of new 5-benzylated 4-oxo-3,4-dihydro-5H-pyridazino[4,5-b]indoles as PI3Kα inhibitors., 57 [PMID:23063566 ] [10.1016/j.ejmech.2012.09.001 ]